Kuwait Implantable Cardiac Rhythm Management (crm) Devices Market Size & Outlook

The implantable cardiac rhythm management (crm) devices market in Kuwait is expected to reach a projected revenue of US$ 47.3 million by 2030. A compound annual growth rate of 4.3% is expected of Kuwait implantable cardiac rhythm management (crm) devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$35.3
Forecast, 2030 (US$M)
$47.3
CAGR, 2024 - 2030
4.3%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait implantable cardiac rhythm management (crm) devices market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Kuwait implantable cardiac rhythm management (crm) devices market highlights

  • The Kuwait implantable cardiac rhythm management (crm) devices market generated a revenue of USD 35.3 million in 2023 and is expected to reach USD 47.3 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
  • In terms of segment, cardiac resynchronization therapy (crt) was the largest revenue generating product in 2023.
  • Implantable Cardioverter Defibrillators (ICDs) is the most lucrative product segment registering the fastest growth during the forecast period.


Implantable cardiac rhythm management (crm) devices market data book summary

Market revenue in 2023USD 35.3 million
Market revenue in 2030USD 47.3 million
Growth rate4.3% (CAGR from 2023 to 2030)
Largest segmentCardiac resynchronization therapy (crt)
Fastest growing segmentImplantable Cardioverter Defibrillators (ICDs)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers
Key market players worldwideStryker Corp, SCHILLER, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp, Koninklijke Philips NV, ZOLL Medical Corporation, BIOTRONIK, Nihon Kohden Corp, MicroPort Scientific Corp


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.3% of the global implantable cardiac rhythm management (crm) devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa implantable cardiac rhythm management (crm) devices market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 125.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Implantable Cardiac Rhythm Management (CRM) devices market Companies

Name Profile # Employees HQ Website
ZOLL Medical Corporation View profile 1001-5000 Chelmsford, Massachusetts, United States, North America http://www.zoll.com/
SCHILLER View profile 501-1000 Feldkirchen, Bayern, Germany, Europe https://www.schillermed.de/
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
BIOTRONIK View profile 5001-10000 Berlin, Berlin, Germany, Europe https://www.biotronik.com/de-de
Nihon Kohden Corp View profile 6325 31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo, Japan, 1618560 http://www.nihonkohden.co.jp
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Koninklijke Philips NV View profile 73712 Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC https://www.philips.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Kuwait implantable cardiac rhythm management (crm) devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardiac rhythm management (crm) devices market will help companies and investors design strategic landscapes.


Cardiac resynchronization therapy (crt) was the largest segment with a revenue share of 42.21% in 2023. Horizon Databook has segmented the Kuwait implantable cardiac rhythm management (crm) devices market based on cardiac resynchronization therapy (crt), implantable cardioverter defibrillators (icds), pacemakers covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Kuwait implantable cardiac rhythm management (crm) devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait implantable cardiac rhythm management (crm) devices market databook

  • Our clientele includes a mix of implantable cardiac rhythm management (crm) devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait implantable cardiac rhythm management (crm) devices market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait implantable cardiac rhythm management (crm) devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait implantable cardiac rhythm management device market size, by cardiac resynchronization therapy (crt), 2018-2030 (US$M)

Kuwait Implantable Cardiac Rhythm Management (CRM) devices market Share, 2023 & 2030 (US$M)

Kuwait implantable cardiac rhythm management device market size, by cardiac resynchronization therapy (crt), 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online